• Please log in or register to access this feature.

Letter to the Editor

You have free access to this content

Response to ‘A controversial consensus’; By the International Consensus Panel

  1. G. Broderick

Article first published online: 30 DEC 2011

DOI: 10.1111/j.1365-2796.2011.02499.x

Issue

Journal of Internal Medicine

Journal of Internal Medicine

Volume 271, Issue 2, pages 213–217, February 2012

Additional Information

How to Cite

Broderick, G. (2012), Response to ‘A controversial consensus’; By the International Consensus Panel. Journal of Internal Medicine, 271: 213–217. doi: 10.1111/j.1365-2796.2011.02499.x

Author Information

  1. From the Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada

*Dr Gordon Broderick, Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, WMC 2E4.41 WC Mackenzie Health Sciences Bldg, 8440-112 Street, Edmonton AB T6G 2R7, Canada. (fax: +17804073027; e-mail: gordon.broderick@ualberta.ca).

Publication History

  1. Issue published online: 17 JAN 2012
  2. Article first published online: 30 DEC 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (94K)

References

  • 1
    Van der Meer J, Lloyd A. A controversial consensus. J Intern Med 2011; Oct 11. DOI: 10.1111/j.1365-2796.2011.02468.x. [Epub ahead of print].
  • 2
    Carruthers BM, van de Sande MI, De Meirleir KL et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270:327–38.
    Direct Link:
  • 3
    Fluge Ø, Bruland O, Risa K et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. PLoS ONE 2011; 6:e26358.
  • 4
    Sharp MC, Archard LC, Banatvala JE et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118–21.
  • 5
    Reeves VC, Wagner D, Nisenbaum R et al. Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med 2005; 3: 19.
  • 6
    Jason LA, Najar N, Porter N, Reh C. Evaluating the Centers for Disease Control’s empirical chronic fatigue syndrome case definition. J Disabil Pol Studies 2009; 20: 91–100.
  • 7
    Fukuda K, Straus SE, Hickie I et al. Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953–9.
  • 8
    Carruthers BM, Jain AK, De Meirleir KL et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003; 11: 7–116.
  • 9
    Jason LA, Torres-Harding SR, Jurgens A, Helgerson J. Comparing the Fukuda et al. Criteria and the Canadian case definition for chronic fatigue syndrome. J Chronic Fatigue Syndr 2004; 12: 37–52.
  • 10
    Van Oosterwijck J, Nijs J, Meeus M et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome; an experimental study. J Intern Med 2010; 268: 265–78. [PMID: 20412374].
    Direct Link:
  • 11
    Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med 2010; 42: 884–90.
  • 12
    Yoshiuchi K, Farkas I, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging 2006; 26: 83–6. [PMID: 16494597].
    Direct Link:
  • 13
    Goldstein JA. Chronic Fatigue Syndrome: The Limbic Hypothesis. Binghamptom, New York: Haworth Medical Press, 1993.
  • 14
    Neary PJ, Roberts AD, Leavins N, Harrison MF, Croll JC, Sexsmith JR. Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome. Clin Physiol Funct Imaging 2008; 28: 364–72. [PMID: 18671793].
    Direct Link:
  • 15
    De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K. Exercise capacity in chronic fatigue syndrome. Arch Intern Med 2000; 170: 3270–13.
  • 16
    VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Post-exertional malaise in women with chronic fatigue syndrome. J Womens Health (Larchmt) 2010; 18: 239–44.
  • 17
    Snell CF, VanNess JM, Stayer DF, Stevens SR. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS). In Vivo 2005; 19: 387–90.
  • 18
    Jones DE, Hollingsworth KG, Jakovljevic DG et al. Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur J Clin Invest 2011; Jun 10. doi: 10.1111/j.1365-2362.2011.02567.x. [Epub ahead of print].
    Direct Link:
  • 19
    Jones DE, Hollingsworth KG, Taylor R, Blamire AM, Newton JL. Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome. J Intern Med 2010; 267: 394–401. [PMID: 20433583].
    Direct Link:
  • 20
    Hollingsworth KG, Jones DE, Taylor R, Blamire AM, Newton JL. Impaired cardiovascular response to standing in chronic fatigue syndrome. Eur J Clin Invest 2010; 40: 608–15. [PMID: 20497461].
    Direct Link:
  • 21
    Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2001; 321: 163–7. [PMID: 11269790].
  • 22
    Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105: 15S–21S. [PMID: 9790477].
  • 23
    Miwa K, Fujita M. Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and “small heart”. J Cardiol 2009; 54: 29–35. [PMID: 19632517].
  • 24
    Peckerman A, LaManca JJ, Qureishi B et al. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome. Psychosom Med 2003; 65: 889–95. [PMID: 14508037].
  • 25
    Peckerman A, LaManca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci 2003; 326: 55–60. [PMID: 12920435].
  • 26
    Lerner AM, Lawrie C, Dworkin HS. Repetitively negative changing T waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome. Left ventricular dysfunction in a cohort. Chest 1993; 104: 1417–21. [PMID: 8222798].
  • 27
    Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88: 767–73. [PMID: 8542261].
  • 28
    Mena I, Villanueva-Meyer J. Study of cerebral perfusion by NeuroSPECT in patients with chronic fatigue syndrome. In: Hyde BM, Goldstein J, Levine P, eds. The Clinical and Scientific Basis of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome. Ottawa, Ontario & Ogdensburg, NY: The Nightingale Research Foundation, 1992; 432–8.
  • 29
    Goldberg MJ, Mena I, Darcourt J. NeuroSPECT findings in children with chronic fatigue syndrome. J Chronic Fatigue Syndr 1997; 3: 61–6.
  • 30
    Ichise M, Salit I, Abbey S et al. Assessment of regional cerebral perfusion by Tc-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1995; 13: 767–72.
  • 31
    Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci 2001; 301: 9–11. [PMID: 21167506].
  • 32
    Schutzer SE, Angel TE, Liu T et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE 2011; 6: e17287.
  • 33
    Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in chronic fatigue syndrome. Am J Med 1998; 105: 50S–3S. [PMID: 9790482].
  • 34
    de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. NeuroImage 2005; 26: 777–81.
  • 35
    Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 2004; 4: 14. [PMID: 15461817].
  • 36
    Mathew SJ, Mao X, Keegan KA et al. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (q)H MRS imaging study. NMR Biomed 2009; 22: 251–8.
    Direct Link:
  • 37
    Meeus M, Nijs J, Huybrechts S, Truijen S. Evidence for generalized hyperalgesia in chronic fatigue syndrome: case control study. Clin Rheumatol 2010; 29: 393–8.
  • 38
    Siemionow V, Fang Y, Calabrese L, Sahgal V, Yue GH. Altered central nervous system signal during motor performance in chronic fatigue syndrome. Clin Neurophysiol 2004; 115: 2372–81. [PMID: 15351380].
  • 39
    Lange G, Steffner J, Cook DB et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. NeuroImage 2005; 26: 513–4. [PMID: 15907308].
  • 40
    Flor-Henry P, Lind JC, Koles ZJ. EEG source analysis of chronic fatigue syndrome. Psychiatry Res 2010; 181: 155–65.
  • 41
    Cook DB, O’Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among fatigue syndrome patients and controls. NeuroImage 2007; 36: 108–22.
  • 42
    Tirelli U, Chierichetti F, Tavio M et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105: 54S–8S.
  • 43
    Cook DB, Lange G, DeLuca J, Natelson BH. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci 2001; 107: 1–6.
  • 44
    Chen R, Liang FX, Moriya J et al. Chronic fatigue syndrome and the central nervous system. J Int Med Res 2008; 36: 867–74.
  • 45
    Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010; 24: 1209–17.
  • 46
    Lorusso L, Mikhaylova SW, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009; 8: 287–91.
  • 47
    Fletcher MA, Zeng XR, Maher K et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV. PLoS ONE 2010; 5: e10817.
  • 48
    Mihaylova I, DeRuyter M, Rummens JL, Basmans E, Maes M. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett 2007; 28: 477–83.
  • 49
    Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–10.
  • 50
    Cameron B, Hirschberg DL, Rosenberg-Hassan Y, Ablashi D, Lloyd AR. Serum cytokine levels in postinfective fatigue syndrome. Clin Infect Dis 2010; 50: 278–9.
  • 51
    Carlo-Stella N, Badulli C, De Sivestri A et al. The first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006; 24: 179–82.
  • 52
    De Meirleir K, Bisbal C, Campine I et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108: 99–105.
  • 53
    Sudolnik RJ, Lombardia V, Peterson DL et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17: 377–85.
  • 54
    Nijs J, Frémont M. Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications. Expert Opin Ther Targets 2008; 12: 281–9.
  • 55
    Nijs J, De Meirleir K, Meeus M, McGregor NR, Englebienne P. Chronic fatigue syndrome: intracellular immune deregulations as a possible etiology for abnormal exercise response. Med Hypotheses 2004; 62: 759–65.
  • 56
    White AT, Light AR, Hughen RW et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology 2010; 47: 615–24.
View Full Article (HTML) Get PDF (94K)